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Summary 
T lymphocyte infiltration is a prominent feature of the skin inflammation associated with infec- 
tions by toxin (superantigen)-secreting Staphylococcus aureus or Streptococcus bacteria.  The cuta- 
neous lymphocyte-associated antigen (CLA) has been hypothesized to be a homing receptor 
(HR.) involved in selective migration of memory/effector  T cells to the skin. Since the expression 
of this putative skin-selective HR is known to be under strict microenvironmental control, we 
sought to determine the effect of staphylococcal and streptococcal  toxins on T cell expression 
of CLA. After in vitro stimulation of peripheral blood mononuclear cells with staphylococcal 
enterotoxin B, toxic shock syndrome toxin-l, and streptococcal pyrogenic exotoxins A and C, 
there was a significant increase in the numbers of CLA + T cell blasts (p <0.01), but not blasts 
bearing the mucosa-associated adhesion molecule c~eB7-integrin, compared with T cells stimu- 
lated with phytohemaglutinin  (PHA) or anti-CD3. Bacterial toxins were also found to specifically 
induce interleukin (IL) 12 production. More importantly, induction of toxin-induced CLA ex- 
pression was blocked by anti-IL-12,  and the addition of IL-12 to PHA-stimulated T cells induced 
CLA, but not ote/~7-integrin,  expression.  These data suggest that bacterial  toxins induce the 
expansion of skin-homing CLA + T  cells in an IL-12-dependent manner, and thus may con- 
tribute to the development of skin rashes in superantigen-mediated diseases. 
S 
taphylococcus  aureus and  streptococcus produce  a  large 
family of exotoxins (1). These toxins cause toxic shock- 
like syndromes and have been implicated in the pathogenesis 
of several allergic and "autoimmune" diseases (2, 3). Included 
within  this  group  of proteins are  the  staphylococcal  en- 
terotoxins (SE), for example, SEB, staphylococcal toxic shock 
syndrome toxin-1 (TSST-1), group A streptococcal pyrogenic 
exotoxins (SPE) A, and SPEC. These toxins are prototypic 
superantigens, which stimulate large populations of T cells 
expressing particular TCR-B chain variable (VB) gene seg- 
ments and activate cytokine release from monocytes/macro- 
phages in an MHC-dependent but unrestricted manner (for 
review see reference 3). 
A prominent feature of diseases thought to be triggered 
by superantigens, for example, toxic shock syndrome, Kawasaki 
syndrome, scarlet fever, atopic dermatitis, and guttate psori- 
asis, is the eruption of skin rashes (2, 4-8). Although it is 
thought that immunologic mechanisms, particularly T cell 
effector  functions, contribute to the pathogenesis of skin 
inflammation in such diseases, the actual events are poorly 
understood. One element of effector T cell function that has 
not been studied in regard to these diseases is their homing 
ability.  Studies  in both animal models and humans have 
demonstrated clear heterogeneity in the ability of previously 
activated  (memory/effector) T  lymphocytes to migrate to 
mucosal versus nonmucosal (e.g., cutaneous) sites (for reviews 
see references 9,  10). This tissue-selective homing is regu- 
lated in large part at the level of lymphocyte recognition of 
postcapillary  venular endothelial cells via the interaction of 
differentially expressed lymphocyte  homing receptors and their 
endothelial cell ligands. In humans, the T lymphocyte mole- 
cule thought to participate in "skin-selective"  lymphocyte 
homing is called the cutaneous lymphocyte-associated an- 
tigen (CLA), which interacts with E-selectin on endothelial 
cells (9-15). 
Skin biopsies from the rashes of patients with superantigen- 
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lymphocytes and the expression of IL-1- and TNF-induced 
vascular  adhesion molecules such as E-selectin  (16, 17). To 
further understand the potential mechanism(s) that results 
in the migration of T lymphocytes into the skin of patients 
with superantigen-mediated infection, we assessed the expres- 
sion of CLA on peripheral blood T cells from normal donors 
at baseline and after stimulation with various staphylococcal 
and streptococcal toxins. Our findings indicate that these toxins 
selectively  induce CLA expression on T  cells by a mecha- 
nism that is,  at least in part,  IL-12 dependent. 
Materials and Methods 
Reagents.  Purified  TSST-1, SEB, SPEA, and SPEC were pre- 
pared by P. M. Schlievert as previously described (18, 19). PHA-M 
was purchased  from either Boehringer-Mannheim  Biochemicals  (In- 
dianapolis, IN) or Wellcome Diagnostics (Greenville, NC). Neu- 
tralizing goat antibodies to human IL-12 (a gift from Dr. John 
Hakimi, Hoffman-La  Roche, Little Falls, NJ) were prepared as pre- 
viously described (20, 21). IL-12 and TGF-/31 were obtained from 
R&D Systems, Inc. (Minneapolis, MN), as were the anti-TGF-~l 
antisera used in this study. IL-2 and anti-IL-4 antisera were ob- 
tained from Genzyme Corp. (Cambridge, MA). mAbs Leu4 (CD3; 
PE; PerCP), Leu3a (CD4; FITC, PE; peridinin chlorophyll protein 
[PerCP]), Leu2a (CD8; FITC, PE; PerCP); G1CL (mouse IgG1 
control; FITC, PE, PerCP), G2GL (mouse IgG2 control; FITC, 
PE), and streptavidin-PE were obtained from Becton Dickinson 
Immunocytometry  Systems (Mountain View, CA). MAb HML-1 
(CD103; ote-integrin; biotin) was obtained from AMAC (West- 
brook, ME), and mAb 2H4 (CD45RA;  PE) was obtained from 
Coulter Immunology (Hialeah, FL). MAb HECA-452 (a rat IgM 
against CLA; FITC), and MECA-79 (used as a rat IgM control; 
FITC) were prepared as previously described (11). To assess TCR 
V/3 repertoire, mAbs directed at different V/3 segments were used. 
These included PE-conjugated mAbs directed to V/32, V33, and 
Vf317, from AMAC, and mAbs directed to V/35.1, V~38.1;8.2, 
V/312, and V/313.1, from T Cell Sciences, Inc. (Cambridge, MA). 
Cell Isolation and Culture.  PBMC obtained from normal donors 
were isolated from heparinized venous blood by density gradient 
sedimentation over Ficoll-Hypaque (Histopaque; Sigma Chemical 
Co., St Louis, MO). Cells were then washed three times in HBSS 
(Gibco Laboratories,  Grand Island,  NY) and resuspended  in medium, 
as appropriate, for either cell culture or immunofluorescence  staining 
of freshly isolated cells. Purified T cells (>95% CD3 §  were iso- 
lated from the PBMC preparations by negative selection by use 
of T cell purification columns (R&D Systems). Purified CLA- 
virgin  (~,99% CLA-CD45RA +)  and memory/effector ()99% 
CLA-CD45RA-) T cells were isolated from T cell preparations 
via fluorescence-activated  cell sorting with the HECA-452 (FITC) 
and 2H4 (PE) mAbs, as previously described (14, 22). 
For cell culture  studies, PBMC  (at  10  ~ cells/ml) or T  cells 
(0.5 x  106 cells/ml) were cultured in RPMI-1640 (Bio-Whittaker, 
Walkersville, MD) supplemented with 10% heat-inactivated FCS 
(Hyclone Sterile Systems, Inc., Logan UT), 20 mM Hepes buffer, 
100 U/ml penicillin, 100 #g/ml streptomycin, and 2 mM r-gluta- 
mine (all from Gibco Laboratories). Cells were cultured in the 
presence of either PHA (1 #g/ml), anti-CD3 (20 ng/ml) or staph- 
ylococcal  or streptococcal  toxins (100 ng/ml) for various  time periods 
(usually 3-5 d), washed, and resuspended in staining buffer for im- 
munofluorescence staining (see below). These concentrations of 
mitogens and superantigens were chosen on the basis of prelimi- 
nary titration studies indicating they were the lowest concentra- 
tions yielding optimal T cell stimulation. In the CLA induction 
studies, IL-12 and TGFq31 were used at 0.2 and 5.0 ng/ml, respec- 
tively (again, these optimal concentrations were determined in ad- 
vance with titration studies). These studies also included 10 U/ml 
IL-2 in the culture media, required to obtain maximal stimulation 
and cell viability during PHA stimulation of the highly purified 
T cells. These levels of IL-2 had no specific  effect  on the expression 
of either CLA or ote/37-integrin  by T cell blasts (data not shown). 
In those experiments that involved analysis of TCR V/3 expres- 
sion, cells were stimulated for 3 d with bacterial toxin, washed 
and allowed to grow for an additional day in the presence of IL-2 
(20 U/ml) before washing, staining with anti-TCR V/3 mAbs, and 
flow cytometric analysis, as previously described (23, 24). 
Cell Staining and Flow Cytometric Analysis.  Five-parameter  anal- 
ysis was performed on a FACScan flow cytometer (Becton Dick- 
inson Immunocytometry Systems)  with FITC, PE, and PerCP used 
as the three fluorescent parameters. Immunofluorescence  staining 
for this multiparameter analysis was performed as previously de- 
scribed (14, 22). Methods of cytometer set up and data acquisition 
have also  been described  previously  (22). List mode multiparameter 
data files (each file with forward scatter, side scatter, and three 
fluorescent parameters) were analyzed by use of either the LYSIS 
II Windows or the PAINT-A-GATE  plu~ programs (Becton Dick- 
inson Immunocytometry Systems). Day 0 analysis  was performed 
by use of a light scatter gate including only viable small lympho- 
cytes, whereas the analysis  of activated populations was performed 
with the light scatter gate set on the T cell blast population. Nega- 
tive control reagents were used to verify the staining specificity 
of experimental antibodies. 
IL-12 Assay.  The quantitation of human IL-12 p40 by sand- 
wich enzyme immunoassay  using 2-4A1 anti-IL-12 p40 as the cap- 
ture antibody was done as previously described (25) with the fol- 
lowing modifications.  Captured IL-12 was detected by addition of 
peroxidase-conjugated 4D6 anti-IL-12 p40 antibody, 250 ng/ml, 
to each well, followed  by incubation for 2 h at room temperature 
with shaking. The plates were developed with TMB (Kirkegaard 
& Perry Labs, Inc., Gaithersburg, MD), the reaction was stopped 
by addition of 1 M H3PO4, and absorbency was measured at 450 
nm. Bioactive human IL-12 was measured by means of an anti- 
body capture bioassay  using Kit225/K6 indicator cells, as described 
by Zhang et al. (25). 
Statistical Analysis.  Data are expressed as the mean _+ SEM for 
each group. Statistical comparisons were made by use of unpaired 
two-tailed t tests with the Stat View 4.0 program (Abacus, Berkeley, 
CA) on a Macintosh Ilcx computer. Analysis  of  variance (ANOVA) 
was used to test differences  in the means of three or more groups. 
When ANOVA was significant, a Fisher's  multiple comparison  pro- 
cedure was used to determine which groups were significantly 
different at the 5% level.  Differences  between groups were consid- 
ered significant at p <0.05. 
Results 
To determine whether bacterial toxins induce the expan- 
sion of CLA + T  cells, we used multiparameter flow cyto- 
metric analysis to examine the expression of CLA on CD3 + 
T cells within freshly isolated PBMC preparations  from seven 
healthy donors versus their T cell blasts after 3 d of in vitro 
incubation with PHA, anti-CD3, SEB, TSST-1,  SPEA, and 
SPEC.  As shown in Fig.  1 (top),  the percentage of CLA + 
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Figure 1.  Bacterial  toxins induce the expansion ofCLA + T cells. (~p) 
CLA + T cell expression was analyzed before and after in vitro stimula- 
tion with PHA (2 #g/ml), anti-CD3 (20 ng/ml), SEB, TSST-1, SPEA, 
and SPEC (100 ng/ml for all toxins)  in seven normal donors.  PBMC 
stimulated with SEB, TSST-1, SPEA, and SPEC had significantly higher 
(*p <0.01, ANOVA) percentages of CLA + T cells than PBMC stimula- 
tion with anti-CD3 or PHA.  In contrast,  bacterial toxins  stimulated 
significantly lower (**p <0.05) levels of ore/37 than PHA or anti-CD3. 
(Bottom)  PBMC were stimulated with either anti-CD3 (20 ng/ml), TSST-1 
(100 ng/ml), or SEB (100 ng/ml) for 3 d, washed, and grown for an addi- 
tional day in the presence of IL-2 (20 U/ml). TSST-1  induced the selective 
expansion of CLA + T  cells expressing V/~2 (*p <0.01 compared with 
anti-CD3-stimulated cells), and SEB induced the selective expansion of 
CLA+ cells expressing V~3, V/~12, and V/~17 (~ <0.01). 
and V317 for SEB) (3), we also examined the T cell reper- 
toire  of CLA + T  cells before and after  stimulation with 
TSST-1 or SEB (Fig. 1,  bottom).  Within the CLA + T cell 
subset,  TSST-1  induced a selective expansion  of V32-ex- 
pressing T  cells, but not T  cells expressing V33,  Vfl5.1, 
VB8.1,8.2, V~12, V~13.1, or V~17 TCKs.  Similarly, SEB 
induced selective expansion of V33-, Vf112- and V317-ex- 
pressing T  cells within the CLA + subset, compared with 
T cells with V32, V35.1,  V38.1,  V38.2, or V~13.1 TCR 
variable regions. 
The observation that bacterial superantigens  (known to 
have stimulatory effects on immune accessory cells such as 
macrophages), but not T  cell mitogens,  induced CLA + T 
cell expansion suggested that an accessory cell product may 
be involved  in this process. We therefore examined the potential 
role of TGF-3I and IL-12 in the induction of CLA + T cells. 
TGF-3I has been previously shown to induce CLA expres- 
sion on mitogen-activated  T  cells (14), whereas IL-12 had 
not been previously tested for this activity. As shown in Fig. 2, 
a neutralizing antiserum to TGF-fll did not significantly in- 
hibit CLA + T cell expansion, suggesting that this cytokine 
did not play a role in bacterial toxin-induced expansion of 
CLA-expressing T  cells. In contrast,  the expansion of the 
CLA + T cell subset by TSST-1 was significantly reduced by 
neutralizing antibodies to IL-12 (2 <0.05), nearly down to 
the percentage of CLA + T cells observed in PHA-stimulated 
cultures. The addition of anti-TGFq31 to anti-IL-12 provided 
no further decrease in the number of CLA + T  cells. 
To further examine the potential  role  of superantigen- 
induced IL-12 production in the stimulation of CLA + T cell 
expansion, we examined IL-12 production in PBMC stimu- 
lated by PHA, SEB, and TSST-1. As demonstrated in Fig. 
3, both SEB and TSST-1 synthesized significantly more im- 
munoreactive and bioactive IL-12 (p <0.01,  ANOVA) than 
PBMC stimulated  with PHA. 
Fig. 4 examines the ability of exogenous IL-12 to regulate 
CLA and ote-integrin expression on PHA-stimulated purified 
T cells did not substantially change after 3 d of in vitro stim-  50- 
ulation with PHA or anti-CD3.  However, the percentage 
of CLA + T  cells was significantly  greater (2 <0.01, ANOVA)  o  40- 
for PBMC stimulated with SEB, TSST-1, SPEA, and SPEC 
compared with cells stimulated with PHA or anti-CD3. Ki-  t-  3o- 
netic analyses demonstrated that increased CLA expression 
by bacterial toxin- versus PHA- or anti-CD3-stimulated T  ~  20- 
blasts first appears at day 3 and is maintained  through day 
5, in keeping with previous kinetic studies of CLA induc-  10- 
tion (14). Both the CD4 and CD8 T cell subsets participated 
in this bacterial toxin-selective induction of CLA, showing  0- 
three- and fourfold increases in CLA-expressing T blasts at 
day 3 over day 0, respectively. In contrast,  the activation- 
dependent induction of the mucosa-associated adhesion mol- 
ecule oee37 (26) by bacterial toxins was significantly less than 
by PHA or anti-CD3 (p <0.05). 
Since bacterial superantigens are known to expand T cells 
in a V3-specific manner (e.g., V/32 for TSST-1; V~3, V312, 
Day 0  PHA  Medium  § anti-  + anti.  + anti-  + anti-lL-12 
[  IL-4  TGF~  IL-12  + anti-rGFBl 
Three day stimulation with TSST-1 
Figure 2.  CLA + T cell expression induced by TSST-1 is dependent on 
IL-12, but not TGF-B. Neutralizing antibody to IL-12 (1 #g/ml) and an- 
tibody to TGF-~ (1 #g/ml) were added to TSST-l-stimulated PBMC. The 
addition of anti-IL-12 caused a significant inhibition of TSST-l-induced 
CLA + T  cell expansion (*p <0.01). 
749  Leung et al. 1000- 
8ooi 
.oi 
4ooi 
A. IL-12 I)40 
Q 
o 
o 
o  o 
o  o 
o  o 
o 
o 
o 
o o 
Medium  L PHA  TSST.I  SEE 
PBMC  ActNatton  S/gnal 
B, BIoIctlvl  It-,2 
300 l  *  * 
200  O O  O 
O  O 
O 
100  0  0 
0  oo 
50  0  O0 
Medium  I  PHA  TS~T-,  SEB 
PBMC Activation Signal 
Figure 3.  Bacterial  toxins, but not PHA, induce IL-12 synthesis  by 
PBMC. PBMC from seven different donors were incubated for 2 d in the 
presence and absence of TSST-1 or SEB (100 ng/ml). PBMC stimulated 
with SEB and TSST-1 synthesized significantly more IL-12 than PBMC 
stimulated with PHA (*p <0.01,  ANOVA). 
T  ceils.  TGF-~I,  which induces T  cell expression of both 
CLA and c~eB7-integrin  (14, 26), was also examined in these 
experiments  for comparative purposes. These data demon- 
strate the ability of IL-12 to selectively increase T  blast ex- 
pression of CLA (p <0.001, ANOVA), but not c~eBT-integrin 
=  NS,  ANOVA),  compared  with  blasts  generated  in 
PHA+IL-2 alone (Fig.  4, top).  This effect was observed for 
both  CD4 +  and  CD8 §  T  ceils;  compared  with  day  5 
mitogen-stimulated T cell cuhures without IL-12, T cell cul- 
tures with IL-12 demonstrated a mean 2.1- (_+0.18; n  =  8) 
and 2.3- (_+0.28; n  =  6) fold increase in CLA + cells among 
the CD4 + and CD8 + subsets, respectively (p  =  NS). The 
lack of an IL-12-mediated cceB7-integrin upregulation was 
not due to a nonspecific lack of responsiveness, as TGF-~I 
mediated a profound upregulation of o~eB7 on the same cells 
(p <0.002,  ANOVA). Finally, we show in the lower panel 
of Fig.  4  that  IL-12 mediates expansion  of CLA + T  cells 
among  highly  purified  CLA-  virgin  (CD45RA +)  and 
memory/effector (CD45RA-)  T  cells,  including  both  the 
CD4 + and CD8 + (CD4-) T cell subsets.  These findings in- 
dicate that the predominant,  if not exclusive,  mechanism of 
IL-12 action  was  the  induction  of CLA  expression,  rather 
than  selective expansion  of preexisting  CLA +  T  cells. 
Discussion 
Skin  infiltration  with  activated  T  cells is  frequently  as- 
sociated with toxin-producing S. aureus and streptococcal in- 
fections,  and is thought  to contribute  to  the pathology of 
the disease caused by these organisms (2, 4-8). It is now well 
established that staphylococcal and  streptococcal toxins en- 
gage class II MHC  antigens on mononuclear  phagocytes to 
induce the release of cytokines such as IL-1~8 and TNF-o~ (27) 
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Figure 4.  Cytokine regulation ofT cell CLA induction in vitro. (~p) 
Purified peripheral blood T cells were incubated for 5 d with PHA and 
IL-2 in the presence of IL-12 (0.2 ng/ml), TGF-/~I (5 ng/ml), or no addi- 
tional cytokines, and then assessed for their expression of CLA (seven ex- 
periments) and  c~e integrin chains  (five experiments). The  results are 
presented as the percentage  (+ SEM) of CLA- or ole integrin-expressing 
T cell blasts at day 5 compared with the same determination among freshly 
prepared small T  cells (day 0). T  cells stimulated with mitogen in the 
presence of either IL-12 or TGF-B1 demonstrated significantly  higher per- 
centages of CLA expressing calls at day 5 than T cells stimulated in the 
absence of these cytokines (*p <0.001, ANOVA). IL-12 had no significant 
effect on the percentage of day 5 T blasts expressing c~e integrin, whereas 
TGF-B1 increased the percentage of ole integrin-expressing ceils almost 
fourfold (significant at F <0.002, ANOVA). Low levels of IL-2 were in- 
cluded in these experiments to maximize the PHA responsiveness of the 
purified T cells; IL-2 by itself does not significantly influence the expres- 
sion of either of the molecules studied (14 and Picker, L. J., data not shown). 
(Bottom) Highly purified CLA-CD45RA+ (virgin) and CLA-CD45RA- 
(memory/effector)  T cells were prepared by flow cytometric cell sorting 
(left column) and then stimulated for 5 d by PHA  +  IL-2 in the presence 
or absence of IL-12. The staining characteristics of these day 5 T blasts 
(essentially all CD3 +) with regard to CLA versus CD4 are indicated in 
the profiles shown, with the quadrants delineating the cutoffs for positive 
and negative staining.  The percentage of CD4 + and CD4- cells that are 
positive for CLA are given in the upper and lower corners,  respectively, 
of each profile. Among the CLA- virgin T cells, pronounced CLA up- 
regulation was observed only in the presence of IL-12. Among the CLA - 
memory/effector T cells, a low level of CLA upregulation (low in terms 
of both percentage positive and staining intensity) was observed in the 
absence of IL-12, but CLA expression by these cells was greatly poten- 
tiated by the addition of IL-12 to the cultures. 
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expressing specific TCR V~ gene segments (3).  Here,  we 
provide  evidence for  yet  another  mechanism  of bacterial 
toxin-mediated modulation of the immune response: induc- 
tion of the skin-selective homing receptor (HR) CLA on toxin- 
activated T  cells. 
Our data indicate that bacterial toxins, for example, SEB, 
and TSST-1 simultaneously stimulate T cells and upregulate 
their expression of CLA. Similar upregulation was not seen 
for c~e~7-integrin, an adhesion molecule thought to selec- 
tively mediate T cell adhesion to mucosal epithelium (10, 28), 
and previous studies have shown that bacterial toxins tend 
to downregulate T  cell expression of the peripheral lymph 
node-selective HR L-selectin (29 and Picker, L. J., unpub- 
lished data). Thus, the available data suggest that T cell acti- 
vation with bacterial toxins appears to selectively alter the 
expression pattern of tissue-selective HR/adhesion molecules 
on the responsive T  cells.  Since a wide variety of data have 
implicated the interaction between CLA and its vascular ligand 
E-selectin as a critical, specificity-determining step in T cell 
extravasation  at cutaneous sites of chronic inflammation (8-15), 
such alteration may well act to selectively increase the skin- 
homing properties of toxin-responsive T  cells,  thereby en- 
hancing the ability of these T cells to participate in cutaneous 
inflammatory processes (see below). 
CLA is not expressed by CD45RAhi/RO l~ virgin T  cells, 
and its presence on a skin-homing CD45RAl~  mem- 
ory/effector T cell subset appears to be initiated by a microen- 
vironmentally controlled induction during the antigen-induced 
virgin to memory/effector T cell conversion in secondary lym- 
phoid tissue (11, 14). At least part of the regulation of this 
induction is tissue specific, as we have previously demonstrated 
that CLA expression on developing memory/effector T cells 
in peripheral lymph node is fivefold higher than that in mu- 
cosal-associated secondary lymphoid tissues (14). While the 
particular microenvironmental factors operating to regulate 
CLA induction in vivo are not understood, we previously 
implicated TGF-/31 as a potent inducer of CLA on activated 
virgin and memory/effector T  cells (14),  and therefore ini- 
tially hypothesized that this pleiotropic cytokine might be 
involved in bacterial toxin-dependent CLA induction. To our 
surprise, we found that (a) bacterial toxins selectively induce 
IL-12 production by PBMC (likely by non-T cells; 30, 31); 
(b) anti-IL-12, but not anti-TGF-~l, antibodies significantly 
inhibit bacterial toxin-mediated CLA induction; and (c) ex- 
ogenous II,-12 is a potent upregulator of CLA on PHA-stimu- 
lated T blasts. These data strongly suggest that toxin-depen- 
dent CLA induction is mediated in large part by IL-12, with 
TGF-/31 having no discernable role. We do not rule out a 
role for TGF-/~I in the regulation of CLA in other physio- 
logic circumstances (i.e.,  situations not involving bacterial 
toxins).  However, it is interesting to note that TGF-~I  is 
a potent upregulator of both CLA and c~eB7, whereas IL-12 
only upregulates CLA (Fig. 4). Since among in vivo T  cell 
populations CLA and o~eB7 expression is usually mutually 
exclusive (15),  II,-12  may well  be  a  physiologically more 
common regulator of CLA than TGF-~I.  IL-12 also has a 
well-documented capability to influence T cell cytokine syn- 
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thesis profiles (32-34), making it possible that this cytokine 
acts indirectly (i.e.,  via intermediates) to upregulate CLA. 
However, we have previously demonstrated that a wide va- 
riety of T cell and non-T cell cytokines have little (IL-6) or 
no (IL-1, -2, -3, -4, -5, -7, -8, -10, TNF-cr  GM-CSF, and 
IFN-30 ability to upregulate CLA (14 and Picker, L. J., un- 
published data),  suggesting that either other,  perhaps un- 
known,  cytokines act  as intermediates,  or that  IL-12  acts 
directly to influence T  cell CLA expression. 
This finding of a distinct, potent regulator of CLA ex- 
pression underscores  the complexity of the regulation  of 
memory/effector T cell function, which is thought to involve 
not only the interplay of immunoregulatory cytokines, but 
perhaps also the nature of the costimulatory signals available 
on different accessory cell subsets and the nature of the anti- 
genic stimulus itself (10, 32, 35, 36). As mentioned above, 
IL-12 has been implicated as a potent modulator of the cytokine 
synthesis potential of memory/effector T  cells, promoting 
the development of effector T cells with a Thl cytokine syn- 
thesis pattern (32-34).  Thus, bacterial toxins would appear 
to have the ability to activate and expand large subsets of 
the peripheral T cell compartment and simultaneously-via 
their IL-12-releasing activity-modulate both the homing 
and effector functions of the responding virgin, and perhaps 
also memory/effector, T  cells. 
These mechanisms may play a major role in the manifesta- 
tion of pathologic sequelae in disorders associated with toxin- 
producing staphylococci or streptococci. In the case of diseases 
associated with local skin infection such as atopic dermatitis 
(7), staphylococcal exotoxins secreted at the skin surface could 
penetrate inflamed skin and stimulate epidermal macrophages 
or Langerhans cells (or perhaps other cell types) to produce 
IL-1, TNF, and IL-12.  Local production of IL-1 and TNF 
would induce the expression of E-selectin on vascular endo- 
thelium (37, 38), allowing an initial influx of CLA + mem- 
ory/effector cells. Local secretion of IL-12 could increase CLA 
expression on those T cells activated by antigen or superan- 
tigen and thereby increase their efficiency of recirculation to 
the skin, perhaps induding areas with only low levels of vas- 
cular E-selectin and minimal inflammatory activity.  IL-12 
secreted by toxin-stimulated Langerhans cells (39), which mi- 
grate to skin-associated lymph nodes (and serve as APC therein; 
40) could upregulate the expression of CLA and influence 
the functional profile of virgin T cells activated by the toxins, 
thereby creating additional skin-homing memory/effector T 
cells.  Together, these mechanisms would tend to markedly 
amplify the initial cutaneous inflammation and perhaps also 
create conditions favoring progression of the staphylococcal 
skin colonization. 
In systemic infections, such as staphylococcal or streptococcal 
toxic  shock  syndrome  or  Kawasaki  syndrome,  increased 
production of IL-1 and TNF by circulating macrophages (17, 
41) and, in the case of Kawasaki syndrome, widespread in- 
duction of cytokine-inducible adhesion molecules on the vas- 
cular endothelium (including postcapillary cutaneous venules; 
17), have been reported. If IL-12 is produced in similar fashion, 
it is possible that generalized T cell activation with concom- 
itant CLA induction could lead to diffuse extravasation of activated T cells at sites of E-selectin induction, particularly 
the skin, contributing to widespread organ damage. 
In summary, this study  provides new insights into the poten- 
tial mechanisms  that  determine the pathogenesis of skin 
inflammation in superantigen-triggered diseases. Moreover, 
the bacterial  toxin  system provides  a  useful paradigm  of 
memory/effector  T cell function in which a single "antigenic" 
stimulus leads to production of functionally specialized effector 
T cells via its ability to simultaneously activate T cells and-via 
signaling a specific accessory cell response-alter the local 
microenvironment supervising the differentiation of the re- 
sponding cells. 
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